Article
Therapeutic potential of crystal-engineered berberine cocrystals ameliorates PCOS phenotypes via AMPK-IRS1/PI3K/Akt axis: An integrative computational and preclinical study.
The Journal of pharmacology and experimental therapeutics - 1 Jul 2026
Kamalakannan Umanath, Sai Durga Surampudi Anuja Venkata, Racha Vyshnavi, Amanchy Ramars, Jain Nishant, Muralidharan Kathirvel
Abstract excerpt
Polycystic ovary syndrome (PCOS) is a complex endocrine-metabolic disorder characterized by hyperandrogenism, chronic anovulation, and insulin resistance, with hyperinsulinemia playing a pivotal role in exacerbating ovarian dysfunction. Although berberine (BBR) exhibits insulin-sensitizing properties, its therapeutic potential is limited by poor oral bioavailability. Our previous study developed BBR cocrystals...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
